Combination Update: Positive Development in
U.S. Antitrust Clearance
DETROIT, March 13,
2025 /PRNewswire/ -- AAM (NYSE: AXL) and Dowlais are
pleased to announce the expiration of the waiting period under the
U.S. Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the "HSR
Act") for the proposed combination of Dowlais with AAM.
The expiration of the waiting period under the HSR Act satisfies
one of the conditions to closing the Combination. Filing processes
in other jurisdictions are progressing and the Combination is
expected to close in the fourth quarter of 2025, subject to
satisfaction of the remaining conditions as set out in the Rule 2.7
announcement released by AAM and Dowlais on 29 January 2025 (the "Rule 2.7
Announcement").
Unless otherwise defined in this announcement, capitalised terms
used in this announcement shall have the same meanings given to
them in the Rule 2.7 Announcement.
Advisors
Allen Overy Shearman Sterling LLP is acting as legal adviser to
AAM in connection with the Combination. Slaughter and May is acting
as legal adviser to Dowlais. Cravath, Swaine & Moore LLP is
acting as U.S. legal adviser to Dowlais.
DISCLAIMERS
Important notices relating to financial advisers
J.P. Morgan Securities LLC, together with its affiliate J.P.
Morgan Securities plc (which conducts its UK investment banking
business as J.P. Morgan Cazenove and which is authorised in the
United Kingdom by the Prudential
Regulation Authority and regulated in the United Kingdom by the Prudential Regulation
Authority and the Financial Conduct Authority). J.P. Morgan is
acting as financial adviser exclusively for AAM and no one else in
connection with the Combination and will not regard any other
person as its client in relation to the Combination and will not be
responsible to anyone other than AAM for providing the protections
afforded to clients of J.P. Morgan or its affiliates, nor for
providing advice in relation to the Combination or any other matter
or arrangement referred to herein.
Barclays, which is authorised by the Prudential Regulation
Authority and regulated in the United
Kingdom by the Financial Conduct Authority and the
Prudential Regulation Authority, is acting exclusively for Dowlais
and no one else in connection with the Combination and will not be
responsible to anyone other than Dowlais for providing the
protections afforded to clients of Barclays nor for providing
advice in relation to the Combination or any other matter referred
to in this announcement.
In accordance with the Code, normal United Kingdom market practice and Rule
14e-5(b) of the Exchange Act, Barclays and its affiliates will
continue to act as exempt principal trader in Dowlais securities on
the London Stock Exchange. These purchases and activities by exempt
principal traders which are required to be made public in the
United Kingdom pursuant to the
Code will be reported to a Regulatory Information Service and will
be available on the London Stock Exchange website at
www.londonstockexchange.com. This information will also be publicly
disclosed in the United States to
the extent that such information is made public in the United Kingdom.
Rothschild & Co, which is authorised and regulated in the UK
by the Financial Conduct Authority, is acting exclusively as
financial adviser to Dowlais and for no–one else in connection with
the Combination and shall not be responsible to anyone other than
Dowlais for providing the protections afforded to clients of
Rothschild & Co, nor for providing advice in connection with
the Combination or any matter referred to herein. Neither
Rothschild & Co nor any of its affiliates (nor their respective
directors, officers, employees or agents) owes or accepts any duty,
liability or responsibility whatsoever (whether direct or indirect,
whether in contract, in tort, under statute or otherwise) to any
person who is not a client of Rothschild & Co in connection
with this announcement, any statement contained herein, the
Combination or otherwise. No representation or warranty, express or
implied, is made by Rothschild & Co as to the contents of this
announcement.
Investec, which is authorised in the United Kingdom by the PRA and regulated in the
United Kingdom by the FCA and the
PRA, is acting exclusively for Dowlais and no one else in
connection with the subject matter of this announcement and will
not regard any other person as its client in relation to the
subject matter of this announcement and will not be responsible to
anyone other than Dowlais for providing the protections afforded to
the clients of Investec, or for providing advice in connection with
the subject matter of this announcement or any other matters
referred to herein. Neither Investec nor any of its subsidiaries,
branches or affiliates owes or accepts any duty, liability or
responsibility whatsoever (whether direct or indirect, whether in
contract, in tort, under statute or otherwise) to any person who is
not a client of Investec in connection with the subject matter of
this announcement, any statement contained herein or otherwise, and
no representation, express or implied, is made by Investec or any
of its subsidiaries, branches or affiliates, or purported to be
made on behalf of Investec or any of its subsidiaries, branches or
affiliates, in relation to the contents of this announcement,
including with regard to the accuracy or completeness of the
announcement or the verification of any other statements made or
purported to be made by or on behalf of Investec or any of its
subsidiaries, branches or affiliates in connection with the matters
described in this announcement.
Further information
This announcement is for information purposes only and is not
intended to, and does not, constitute or form part of any offer or
invitation to purchase, otherwise acquire, subscribe for, sell or
otherwise dispose of, any securities or the solicitation of any
vote or approval in any jurisdiction pursuant to the Combination or
otherwise. In particular, this announcement is not an offer of
securities for sale into the U.S. No offer of securities shall be
made in the U.S. absent registration under the U.S. Securities Act,
or pursuant to an exemption from, or in a transaction not subject
to, such registration requirements. The Combination will be made
solely through the Scheme Document (or, if the Combination is
implemented by way of a Takeover Offer, the Takeover Offer
documents), which, together with the accompanying Forms of Proxy
and Forms of Election in relation to the Mix and Match Facility,
which will contain the full terms and conditions of the
Combination, including details of how to vote in respect of the
Combination. Any decision in respect of the Combination should be
made only on the basis of the information in the Scheme Document
(or, if the Combination is implemented by way of a Takeover Offer,
the Takeover Offer documents).
Dowlais will prepare the Scheme Document to be distributed to
Dowlais Shareholders. Dowlais and AAM urge Dowlais Shareholders to
read the Scheme Document (or any other document by which the
Combination is made) in full when it becomes available because it
will contain important information relating to the Combination,
including details of how to vote in respect of the Scheme.
The statements contained in this announcement are made as at the
date of this announcement, unless some other time is specified in
relation to them, and publication of this announcement shall not
give rise to any implication that there has been no change in the
facts set forth in this announcement since such date.
This announcement does not constitute a prospectus or a
prospectus equivalent document.
This announcement has been prepared for the purpose of complying
with English law and the Code and the information disclosed may not
be the same as that which would have been disclosed if this
announcement had been prepared in accordance with the laws of
jurisdictions outside England.
The Combination will be subject to the applicable requirements
of English law, the Code, the Panel, the London Stock Exchange and
the FCA.
Neither the SEC nor any U.S. state securities commission has
approved, disproved or passed judgment upon the fairness or the
merits of the Combination or determined if this announcement is
adequate, accurate or complete. Any representation to the contrary
is a criminal offence in the U.S.
Overseas Shareholders
The release, publication or distribution of this announcement in
jurisdictions other than the UK, and the availability of the
Combination to Dowlais Shareholders who are not resident in the UK,
may be restricted by law and therefore any persons who are not
resident in the UK or who are subject to the laws of any
jurisdiction other than the UK (including Restricted Jurisdictions)
should inform themselves about, and observe, any applicable legal
or regulatory requirements. In particular, the ability of persons
who are not resident in the UK or who are subject to the laws of
another jurisdiction to participate in the Combination or to vote
their Dowlais Shares in respect of the Scheme at the Court Meeting,
or to execute and deliver Forms of Proxy appointing another to vote
at the Court Meeting on their behalf, may be affected by the laws
of the relevant jurisdictions in which they are located or to which
they are subject. Any failure to comply with applicable legal or
regulatory requirements of any jurisdiction may constitute a
violation of securities laws in that jurisdiction. To the fullest
extent permitted by applicable law, the companies and persons
involved in the Combination disclaim any responsibility or
liability for the violation of such restrictions by any person.
Unless otherwise determined by AAM or required by the Code, and
permitted by applicable law and regulation, the Combination shall
not be made available, directly or indirectly, in, into or from a
Restricted Jurisdiction where to do so would violate the laws in
that jurisdiction and no person may vote in favour of the
Combination by any such use, means, instrumentality or form within
a Restricted Jurisdiction or any other jurisdiction if to do so
would constitute a violation of the laws of that jurisdiction.
Accordingly, copies of this announcement and any formal
documentation relating to the Combination are not being, and must
not be, directly or indirectly, mailed or otherwise forwarded,
distributed or sent in or into or from any Restricted Jurisdiction
or any jurisdiction where to do so would constitute a violation of
the laws of such jurisdiction and persons receiving such documents
(including custodians, nominees and trustees) must not mail or
otherwise forward, distribute or send them in or into or from any
Restricted Jurisdiction. Doing so may render invalid any related
purported vote in respect of acceptance of the Combination.
Further details in relation to Dowlais Shareholders in overseas
jurisdictions will be contained in the Scheme Document (or, if the
Combination is implemented by way of a Takeover Offer, the Takeover
Offer documents).
Additional information for U.S. investors in Dowlais
The Combination relates to an offer for the shares of an English
company and is proposed to be implemented by means of a scheme of
arrangement provided for under English company law. The
Combination, implemented by way of a scheme of arrangement, is not
subject to the tender offer rules or the related proxy solicitation
rules under the U.S. Exchange Act. Accordingly, the Combination is
subject to the disclosure requirements and practices applicable to
a scheme of arrangement involving a target company in the UK listed
on the London Stock Exchange, which differ from the disclosure
requirements of the U.S. tender offer and related proxy
solicitation rules. If, in the future, AAM exercises its right to
elect to implement the Combination by way of a Takeover Offer and
determines to extend the Takeover Offer into the U.S., such
Takeover Offer will be made in compliance with applicable U.S. laws
and regulations.
The New AAM Shares to be issued pursuant to the Combination have
not been and will not be registered under the U.S. Securities Act,
and may not be offered or sold by AAM in the U.S. absent
registration or an applicable exemption from the registration
requirements of the U.S. Securities Act. The New AAM Shares to be
issued pursuant to the Combination will be issued pursuant to the
exemption from registration set forth in Section 3(a)(10) of the
U.S. Securities Act. If, in the future, AAM exercises its right to
elect to implement the Combination by way of a Takeover Offer or
otherwise determines to conduct the Combination in a manner that is
not exempt from the registration requirements of the U.S.
Securities Act, it will file a registration statement with the SEC
that will contain a prospectus with respect to the issuance of New
AAM Shares. In this event, Dowlais Shareholders are urged to read
these documents and any other relevant documents filed with the
SEC, as well as any amendments or supplements to all such
documents, because they will contain important information, and
such documents will be available free of charge at the SEC's
website at www.sec.gov or by directing a request to AAM's
contact for enquiries identified above.
This announcement contains, and the Scheme Document will contain
certain unaudited financial information relating to Dowlais that
has been prepared in accordance with UK-endorsed International
Financial Reporting Standards ("IFRS") and thus may not be
comparable to financial information of U.S. companies or companies
whose financial statements are prepared in accordance with U.S.
generally accepted accounting principles. U.S. generally accepted
accounting principles differ in certain significant respects from
IFRS.
Dowlais is incorporated under the laws of a non-U.S.
jurisdiction, some or all of Dowlais' officers and directors reside
outside the U.S., and some or all of Dowlais' assets are or may be
located in jurisdictions outside the U.S. Therefore, U.S. Dowlais
Shareholders (defined as Dowlais Shareholders who are U.S. persons
as defined in the U.S. Internal Revenue Code or "IRC") may have
difficulty effecting service of process within the U.S. upon those
persons or recovering against Dowlais or its officers or directors
on judgments of U.S. courts, including judgments based upon the
civil liability provisions of the U.S. federal securities laws.
Further, it may be difficult to compel a non-U.S. company and its
affiliates to subject themselves to a U.S. court's judgment. It may
not be possible to sue Dowlais or its officers or directors in a
non-U.S. court for violations of the U.S. securities laws.
The receipt of New AAM Shares and cash by Dowlais Shareholders
as consideration for the transfer of Dowlais Shares pursuant to the
Combination may be a taxable transaction for U.S. federal income
tax purposes and under applicable U.S. state and local, as well as
foreign and other, tax laws. Such consequences, if any, are not
generally described herein. Each Dowlais Shareholder is urged to
consult with legal, tax and financial advisers in connection with
making a decision regarding the Combination, including in light of
the potential application of Section 304 of the IRC to the
Combination.
Forward-looking statements
In this announcement, AAM makes statements concerning its and
Dowlais' expectations, beliefs, plans, objectives, goals,
strategies, and future events or performance, including, but not
limited to, certain statements related to the ability of AAM and
Dowlais to consummate AAM's business combination with Dowlais (the
"Business Combination") in a timely manner or at all; future
capital expenditures, expenses, revenues, economic performance,
synergies, financial conditions, market growth, dividend policy,
losses and future prospects and business; and management strategies
and the expansion and growth of AAM's and the combined company's
operations. Such statements are "forward-looking" statements within
the meaning of the Private Securities Litigation Reform Act of 1995
and relate to trends and events that may affect AAM's or the
combined company's future financial position and operating results.
The terms such as "will," "may," "could," "would," "plan,"
"believe," "expect," "anticipate," "intend," "project," "target,"
and similar words or expressions, as well as statements in future
tense, are intended to identify forward-looking statements.
Forward-looking statements should not be read as a guarantee of
future performance or results and will not necessarily be accurate
indications of the times at, or by, which such performance or
results will be achieved. These forward-looking statements involve
certain risks and uncertainties that could cause actual results to
differ materially from those expressed or implied by these
statements. These risks and uncertainties related to AAM
include factors detailed in the reports AAM files with the United
States Securities and Exchange Commission (the "SEC"), including
those described under "Risk Factors" in its most recent Annual
Report on Form 10-K and its Quarterly Reports on Form 10-Q. These
forward-looking statements speak only as of the date of this
communication. AAM expressly disclaims any obligation or
undertaking to disseminate any updates or revisions to any
forward-looking statement contained herein to reflect any change in
its or Dowlais' expectations with regard thereto or any change in
events, conditions or circumstances on which any such statement is
based.
Additional Information
This announcement may be deemed to be solicitation material in
respect of the Business Combination, including the issuance of
AAM's shares of common stock in respect of the Business
Combination. In connection with the foregoing proposed issuance
of AAM's shares of common stock, AAM expects to file a proxy
statement on Schedule 14A (together with any amendments and
supplements thereto, the "Proxy Statement") with the SEC. To the
extent the Business Combination is effected as a scheme of
arrangement under English law, the issuance of AAM's shares of
common stock in connection with the Business Combination would not
be expected to require registration under the U.S. Securities Act
of 1933, as amended (the "Securities Act"), pursuant to an
exemption provided by Section 3(a)(10) under the Securities Act. In
the event that AAM exercises its right to elect to implement the
Business Combination by way of a takeover offer (as defined in the
UK Companies Act 2006) or otherwise determines to conduct the
Business Combination in a manner that is not exempt from the
registration requirements of the Securities Act, AAM expects to
file a registration statement with the SEC containing a prospectus
with respect to the AAM's shares that would be issued in the
Business Combination. INVESTORS AND SHAREHOLDERS ARE URGED TO READ
THE PROXY STATEMENT, THE SCHEME DOCUMENT, AND OTHER RELEVANT
DOCUMENTS FILED OR TO BE FILED BY AAM WITH THE SEC OR INCORPORATED
BY REFERENCE IN THE PROXY STATEMENT (IF ANY) CAREFULLY WHEN THEY
BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION
ABOUT AAM, THE BUSINESS COMBINATION AND RELATED MATTERS. Investors
and shareholders will be able to obtain free copies of the Proxy
Statement, the scheme document, and other documents filed by AAM
with the SEC at the SEC's website at http://www.sec.gov . In
addition, investors and shareholders will be able to obtain free
copies of the Proxy Statement, the scheme document, and other
documents filed by AAM with the SEC at
https://www.aam.com/investors.
Participants in the Solicitation
AAM and its directors, executive officers and certain other
members of management and employees will be participants in the
solicitation of proxies from AAM's shareholders in respect of the
Business Combination, including the proposed issuance of AAM's
shares of common stock in connection with the Business Combination.
Information regarding AAM's directors and executive officers
is contained in its Annual Report on Form 10-K for the fiscal year
ended December 31, 2023, which was
filed with the SEC on February 16,
2024, the definitive proxy statement on Schedule 14A for
AAM's 2024 annual meeting of stockholders, which was filed with the
SEC on March 21, 2024 and the Current
Report on Form 8-K of AAM, which was filed with the SEC on
May 2, 2024. Additional information
regarding the identity of participants, and their direct or
indirect interests, by security holdings or otherwise, will be set
forth in the Proxy Statement when it is filed with the SEC. To the
extent holdings of AAM's securities by its directors or
executive officers change from the amounts set forth in the Proxy
Statement, such changes will be reflected on Initial Statements of
Beneficial Ownership on Form 3 or Statements of Change in Ownership
on Form 4 filed with the SEC by AAM. These documents may be
obtained free of charge from the SEC's website at www.sec.gov
and AAM's website at https://www.aam.com/investors.
No Offer or Solicitation
This announcement is not intended to and shall not constitute an
offer to sell or the solicitation of an offer to sell or the
solicitation of an offer to buy any securities or a solicitation of
any vote of approval, nor shall there be any sale of securities in
any jurisdiction in which such offer, solicitation or sale would be
unlawful prior to registration or qualification under the
securities laws of any such jurisdiction.
Publication on website
This announcement is required to be published pursuant to Rule
26 of the Code and will be available, subject to certain
restrictions relating to persons resident in Restricted
Jurisdictions, on AAM's website at https://www.aam.com/investors
and on Dowlais' website at http://www.dowlais.com promptly and in
any event by no later than 12 noon (London time) on the business day (as defined
in the Code) following the date of this announcement. Neither the
content of the websites referred to in this announcement nor the
content of any website accessible from hyperlinks in this
announcement is incorporated into, or forms part of, this
announcement.
Dowlais Shareholders and persons with information rights may,
subject to applicable securities laws, request a hard copy of this
announcement, free of charge, by contacting Dowlais' registrars,
Equiniti, by: (i) submitting a request in writing to Equiniti at
Aspect House, Spencer Road, Lancing, West
Sussex BN99 6DA, United
Kingdom; or (ii) contacting Equiniti between 8.30 a.m. and 5.30 p.m. (London time), Monday to Friday (excluding
English and Welsh public holidays), on +44 (0) 371 384 2030 (please
use the country code when calling from outside the UK). A person so
entitled may, subject to applicable securities laws, also request
that all future documents, announcements and information to be sent
in relation to the Combination should be in hard copy form.
Rounding
Certain figures included in this announcement have been
subjected to rounding adjustments. Accordingly, figures shown for
the same category presented in different tables may vary slightly
and figures shown as totals in certain tables may not be an
arithmetic aggregation of the figures that precede them.
General
If you are in any doubt about the contents of this announcement
or the action you should take, you are recommended to seek your own
independent financial advice immediately from your stockbroker,
bank manager, solicitor, accountant or independent financial
adviser duly authorised under FSMA if you are resident in the
United Kingdom or, if not, from
another appropriately authorised independent financial adviser.
Contacts
|
|
|
|
For AAM
Investor Contact
David H. Lim
Head of Investor
Relations
+1 313 758
2006
david.lim@aam.com
Media Contact
Christopher M.
Son
Vice President,
Marketing & Communications
+1 313 758
4814
chris.son@aam.com
J.P. Morgan (Exclusive financial adviser
to AAM)
David Walker / Ian
MacAllister
+1 (212) 270
6000
Robert Constant
/ Jonty Edwards
+44 (0) 203 493
8000
FGS Global (PR adviser to
AAM)
Jared Levy/Jim
Barron
+1 212 687
8080
Charlie Chichester/Rory King
+44 20 7251
3801
AAM@fgsglobal.com
|
For Dowlais
Investor Contact:
Pier
Falcione
+44 (0) 7855
185420
investor.relations@dowlais.com
Barclays Bank PLC, acting through its Investment
Bank
("Barclays") (Financial adviser and corporate broker to
Dowlais)
Guy Bomford / Adrian
Beidas / Neal West (Corporate Broking)
+44 (0) 20 7623
2323
Rothschild & Co (Financial adviser to
Dowlais)
Ravi Gupta / Nathalie
Ferretti
+44 (0) 20 7280
5000
Investec Bank plc (Joint corporate broker to
Dowlais)
Carlton Nelson /
Christopher Baird
+44 (0) 20 7597
5970
Montfort Communications (PR adviser to
Dowlais)
Nick Miles
+44 (0) 7739
701634
miles@montfort.london
Neil Craven
+44 (0) 7876
475419
craven@montfort.london
|
|
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/recommended-cash-and-share-combination-of-dowlais-group-plc-dowlais-with-american-axle--manufacturing-holdings-inc-aam-302400480.html
SOURCE American Axle & Manufacturing Holdings, Inc.